Studying the immunocomplex phagocytosis in erythematodes

A. Horváth, E. Ablonczy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The DNA anti DNA hetero-immunocomplex phagocytosing capacity of polymorphonuclear leukocytes of patients with discoid and systematic lupus erythematodes in 22 different periods is studied by the authors. The phagocyte capacity of normal control group performed by a cytomorphologic system has been 24 ± 2.4%, with the DLE/S group 13.2 ± 1.6%, with the SLE-group 11 ± 1.77%. The decreased phagocyte function has been significantly evaluable in the SLE and DLE/S groups; at the same time however in the DLE-cases demonstrating only skin symptoms no difference of evaluable degree has been found in comparison to the normal control group.

Original languageEnglish
Title of host publicationRheumatologia Balneologia Allergologia
Pages9-12
Number of pages4
Volume20
Edition1
Publication statusPublished - 1979

Fingerprint

Phagocytes
Phagocytosis
Control Groups
DNA
Neutrophils
Skin

ASJC Scopus subject areas

  • Rheumatology

Cite this

Horváth, A., & Ablonczy, E. (1979). Studying the immunocomplex phagocytosis in erythematodes. In Rheumatologia Balneologia Allergologia (1 ed., Vol. 20, pp. 9-12)

Studying the immunocomplex phagocytosis in erythematodes. / Horváth, A.; Ablonczy, E.

Rheumatologia Balneologia Allergologia. Vol. 20 1. ed. 1979. p. 9-12.

Research output: Chapter in Book/Report/Conference proceedingChapter

Horváth, A & Ablonczy, E 1979, Studying the immunocomplex phagocytosis in erythematodes. in Rheumatologia Balneologia Allergologia. 1 edn, vol. 20, pp. 9-12.
Horváth A, Ablonczy E. Studying the immunocomplex phagocytosis in erythematodes. In Rheumatologia Balneologia Allergologia. 1 ed. Vol. 20. 1979. p. 9-12
Horváth, A. ; Ablonczy, E. / Studying the immunocomplex phagocytosis in erythematodes. Rheumatologia Balneologia Allergologia. Vol. 20 1. ed. 1979. pp. 9-12
@inbook{29a58802ccc340af979bcad6d70ff846,
title = "Studying the immunocomplex phagocytosis in erythematodes",
abstract = "The DNA anti DNA hetero-immunocomplex phagocytosing capacity of polymorphonuclear leukocytes of patients with discoid and systematic lupus erythematodes in 22 different periods is studied by the authors. The phagocyte capacity of normal control group performed by a cytomorphologic system has been 24 ± 2.4{\%}, with the DLE/S group 13.2 ± 1.6{\%}, with the SLE-group 11 ± 1.77{\%}. The decreased phagocyte function has been significantly evaluable in the SLE and DLE/S groups; at the same time however in the DLE-cases demonstrating only skin symptoms no difference of evaluable degree has been found in comparison to the normal control group.",
author = "A. Horv{\'a}th and E. Ablonczy",
year = "1979",
language = "English",
volume = "20",
pages = "9--12",
booktitle = "Rheumatologia Balneologia Allergologia",
edition = "1",

}

TY - CHAP

T1 - Studying the immunocomplex phagocytosis in erythematodes

AU - Horváth, A.

AU - Ablonczy, E.

PY - 1979

Y1 - 1979

N2 - The DNA anti DNA hetero-immunocomplex phagocytosing capacity of polymorphonuclear leukocytes of patients with discoid and systematic lupus erythematodes in 22 different periods is studied by the authors. The phagocyte capacity of normal control group performed by a cytomorphologic system has been 24 ± 2.4%, with the DLE/S group 13.2 ± 1.6%, with the SLE-group 11 ± 1.77%. The decreased phagocyte function has been significantly evaluable in the SLE and DLE/S groups; at the same time however in the DLE-cases demonstrating only skin symptoms no difference of evaluable degree has been found in comparison to the normal control group.

AB - The DNA anti DNA hetero-immunocomplex phagocytosing capacity of polymorphonuclear leukocytes of patients with discoid and systematic lupus erythematodes in 22 different periods is studied by the authors. The phagocyte capacity of normal control group performed by a cytomorphologic system has been 24 ± 2.4%, with the DLE/S group 13.2 ± 1.6%, with the SLE-group 11 ± 1.77%. The decreased phagocyte function has been significantly evaluable in the SLE and DLE/S groups; at the same time however in the DLE-cases demonstrating only skin symptoms no difference of evaluable degree has been found in comparison to the normal control group.

UR - http://www.scopus.com/inward/record.url?scp=0018350061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018350061&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:0018350061

VL - 20

SP - 9

EP - 12

BT - Rheumatologia Balneologia Allergologia

ER -